Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
Emily J. LodgeiD, Alice SantambrogioiD, John P. RusselliD, Paraskevi XekoukiiD, Thomas S. JacquesiD, Randy L. JohnsoniD, Selvam ThavarajiD, Stefan Richard BornsteiniD, Cynthia L. AndoniadouiD
Abstract
SOX2 positive pituitary stem cells (PSCs) are specified embryonically and persist throughout life, giving rise to all pituitary endocrine lineages. We have previously shown the activation of the MST/LATS/YAP/TAZ signalling cascade in the developing and postnatal mammalian pituitary. Here, we investigate the function of this pathway during pituitary development and in the regulation of the SOX2 cell compartment. Through loss- and gain-of-function genetic approaches, we reveal that restricting YAP/TAZ activation during development is essential for normal organ size and specification from SOX2+ PSCs. Postnatal deletion of LATS kinases and subsequent upregulation of YAP/TAZ leads to uncontrolled clonal expansion of the SOX2+ PSCs and disruption of their differentiation, causing the formation of non-secreting, aggressive pituitary tumours. In contrast, sustained expression of YAP alone results in expansion of SOX2+ PSCs capable of differentiation and devoid of tumourigenic potential. Our findings identify the LATS/YAP/TAZ signalling cascade as an essential component of PSC regulation in normal pituitary physiology and tumourigenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 40
- FWCI
- 2.91
- Field percentile
- top 10%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pituitary stem cells produce paracrine WNT signals to control the expansion of their descendant progenitor cells
John P. Russell, Xinhong Lim, … Cynthia L. Andoniadou·eLifePeer-reviewed·Jan 5, 2021
- SOX2 is required independently in both stem and differentiated cells for pituitary tumorigenesis in p27 null mice.
V. Moncho-Amor, P. Chakravarty, … K. Rizzoti·bioRxiv·Jun 9, 2020
- Transcriptomic heterogeneity of Sox2-expressing pituitary cells
Patrick A. Fletcher, Kosara Smiljanić, … Stanko S. Stojilković·GliaPeer-reviewed·Sep 12, 2022
- SOX9-positive pituitary stem cells differ according to their position in the gland and maintenance of their progeny depends on context.
Karine Rizzoti, Probir Chakravarty, … Robin Howard Lovell-Badge·Science AdvancesPeer-reviewed·Oct 4, 2023
- Decoding the activated stem cell phenotype of the vividly maturing neonatal pituitary
Emma Laporte, Florian Hermans, … Hugo E J Vankelecom·eLifePeer-reviewed·Jun 14, 2022
- Heterogeneity of Sox2-expressing cells in mouse pituitary and their roles in postnatal gonadotroph differentiation
Kosara Smiljanić, Stéphanie Constantin, … Stanko S. Stojilković·Molecular and Cellular EndocrinologyPeer-reviewed·Oct 1, 2025